Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00421_DB00966_nanopub.RAIhF5Qd4Z2ezgF3HTRP6OgQaHy1sltlJuIijvIgHfkvs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00421_DB00966 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00421_DB00966 label "DDI between Spironolactone and Telmisartan - Telmisartan may increase the hyperkalemic effect of Spironolactone. Monitor for increased serum potassium concentrations during concomitant therapy. [drugbank_resource:DB00421_DB00966]" assertion.
- drugbank_resource:DB00421_DB00966 identifier "drugbank_resource:DB00421_DB00966" assertion.
- drugbank_resource:DB00421_DB00966 title "DDI between Spironolactone and Telmisartan - Telmisartan may increase the hyperkalemic effect of Spironolactone. Monitor for increased serum potassium concentrations during concomitant therapy." assertion.
- drugbank:DB00421 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00421_DB00966 assertion.
- drugbank:DB00966 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00421_DB00966 assertion.